Show simple item record

dc.contributor.authorNeumann, I.
dc.contributor.authorQuiñelen, E.
dc.contributor.authorNahuelhual, P.
dc.contributor.authorBurdiles, P.
dc.contributor.authorCeledón, N.
dc.contributor.authorCerda, K.
dc.contributor.authorHerrera-Omegna, P.
dc.contributor.authorKraemer, P.
dc.contributor.authorCancino, K.D.
dc.contributor.authorValenzuela, J.P.
dc.contributor.authorSepúlveda, D.
dc.contributor.authorMorgano, G.P.
dc.contributor.authorAkl, E.A.
dc.contributor.authorSchünemann, H.J.
dc.date.accessioned2025-10-31T18:35:34Z
dc.date.available2025-10-31T18:35:34Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5299
dc.description.abstractObjectives: Guideline panels must assess the magnitude of health benefits and harms to develop sensible recommendations. However, they rarely use explicit thresholds. In this paper we report on the piloting and the use thresholds for benefits and harms. Study Design and Setting: We piloted the use of thresholds in a Chilean COVID-19 living guideline. For each of the critical outcomes, we asked panelists to suggest values of the thresholds for large, moderate, small, or trivial or no effect. We collected this information through a survey and an on-line discussion. Results: Twelve panelists decided on thresholds for three critical outcomes (mortality, need for mechanical ventilation and serious adverse events). For all outcomes, an absolute risk reduction was considered larger with more than 50 events, moderate with less than 50 events, small with less than 25 events, and trivial with less than 10 events. Having these a priori thresholds in place significantly impacted on the development of recommendations. Conclusion: Explicit thresholds were a valuable addition to the judgment of the certainty in the evidence, to decide the direction and strength of the recommendation and to evaluate the need for update. We believe this is a line of research worth perusing.en_US
dc.description.sponsorshipConflict of interest: This work had no specific funding. All authors declare no conflict of interest.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1878-5921
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectPatient-Centered Approaches in Health Care Qualityen_US
dc.subjectGuideline Development and Quality Assessment in Healthcareen_US
dc.titleUsing explicit thresholds for benefits and harms in partially contextualized GRADE guidelines. Pilot experience from a living COVID-19 guidelineen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1016/j.jclinepi.2022.03.017
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05
dc.type.otherResearch article
dc.identifier.journalJournal of Clinical Epidemiology
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2